Top broker says Bellamy’s Australia Ltd shares are worth $14.40

It has been another positive day for the Bellamy’s Australia Ltd (ASX: BAL) share price.

In morning trade the organic infant formula and baby food company’s shares are up 3% to $11.75.

Why are its shares higher today?

With no news out of the company this morning, the catalyst for today’s gain appears to be a positive research note out of Citi.

According to the note, the broker has upgraded Bellamy’s all the way from a sell rating to a (high risk) buy rating.

Furthermore, Citi has increased its price target on Bellamy’s shares to $14.40 from just $7.90. This price target implies potential upside of over 22% from the current share price.

Citi appears to have been impressed with the Bellamy’s turnaround and sees little by way of negative news flow on the horizon to stop its strong run from continuing.

Should you invest?

Although Citi has had a change of heart, I’m still not yet convinced that Bellamy’s is anything better than a hold at the current share price.

Like Citi, I have been very impressed with the Bellamy’s turnaround and believe management should be commended.

However, at 39x estimated forward earnings, I would prefer to buy in at a lower price in order to get a more compelling risk/reward.

But admittedly, considering the premium that investors are willing to pay for infant formula companies such as Bubs Australia Ltd (ASX: BUB) and a2 Milk Company Ltd (Australia) (ASX: A2M), such an opportunity may not arise.

In the meantime, I think investors ought to consider one of these top growth shares instead of Bellamy's. Each has strong growth prospects and trade on reasonable valuations in my opinion.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.